Advertisement

week in cancer news

  • July 30: The Week in Cancer News

    Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

    by Marci A. Landsmann

  • July 23: The Week in Cancer News

    Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

    by Kevin McLaughlin

  • July 16: The Week in Cancer News

    A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

    by Bradley Jones

  • July 9: The Week in Cancer News

    Study shows cancer centers can improve coordination with physicians’ practices in their networks, and cancer death rates in U.S. continue to decline.

    by Marci A. Landsmann

  • July 2: The Week in Cancer News

    A study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.

    by Kevin McLaughlin

  • June 25: The Week in Cancer News

    A reporter discusses the elevated risk for early-onset colorectal cancer in Black men, and a study shows that women are underrepresented in cancer clinical trials.

    by Kate Yandell

  • June 18: The Week in Cancer News

    A study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.

    by Bradley Jones

  • June 11: Week in Cancer News

    Triplet therapy shows promise for prostate cancer that was metastatic at diagnosis, and Americans report inadequate knowledge of palliative care.

    by Marci A. Landsmann

  • June 4: The Week in Cancer News

    A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.

    by Kevin McLaughlin

  • May 28: The Week in Cancer News

    A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.

    by Kate Yandell

Advertisement
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR